ArriVent BioPharma (AVBP) Stock Chart & Stock Price History $28.96 -0.06 (-0.19%) As of 12:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ArriVent BioPharma Stock Price Performance 5 Day Performance+6.30%1 Month Performance+7.68%3 Month Performance-7.79%6 Month Performance+31.91%Year-To-Date Performance+8.93%1 Year Performance+31.91% Receive AVBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address AVBP Stock Chart for Thursday, January, 30, 2025 AVBP Chart by TradingView ArriVent BioPharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/29/2025$28.80$29.02+0.76%$29.60$28.50128,969 shs$977.97 million01/28/2025$28.24$28.80+1.98%$28.98$28.05214,080 shs$970.56 million01/27/2025$27.30$28.24+3.44%$28.35$26.79226,256 shs$951.60 million01/24/2025$27.25$27.30+0.18%$27.93$26.4196,493 shs$920.01 million01/23/2025$26.63$27.25+2.33%$27.70$26.32135,999 shs$897.35 million01/22/2025$25.31$26.63+5.22%$27.10$25.90187,725 shs$897.43 million01/21/2025$24.41$25.31+3.69%$26.15$24.42127,459 shs$852.95 million01/20/2025$24.41$24.41$25.49$23.84107,553 shs$822.62 million01/17/2025$24.48$24.41-0.29%$25.49$23.84107,553 shs$822.62 million01/16/2025$24.92$24.48-1.77%$24.73$23.63105,773 shs$824.98 million Get the Latest News and Ratings for AVBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. 01/15/2025$24.85$24.92+0.28%$26.54$24.69159,090 shs$839.73 million01/14/2025$25.42$24.85-2.24%$25.77$24.13142,463 shs$837.37 million01/13/2025$24.88$25.42+2.17%$25.54$23.80100,264 shs$856.58 million01/10/2025$26.86$24.88-7.37%$27.11$23.97238,242 shs$838.38 million01/09/2025$26.86$26.86$27.34$26.30143,839 shs$905.10 million01/08/2025$26.84$26.86+0.07%$27.34$26.30143,839 shs$905.10 million01/07/2025$26.15$26.84+2.64%$26.93$25.6890,276 shs$904.43 million01/06/2025$27.52$26.15-4.98%$27.31$25.76106,637 shs$881.18 million01/03/2025$27.47$27.52+0.18%$28.50$26.79115,211 shs$927.34 million01/02/2025$26.64$27.47+3.12%$27.81$26.80151,100 shs$925.66 million01/01/2025$26.64$26.64$27.22$26.3687,561 shs$897.69 million12/31/2024$26.95$26.64-1.15%$27.22$26.3687,561 shs$897.69 million12/30/2024$27.26$26.95-1.14%$27.50$26.39179,114 shs$908.13 million Related Companies Viking Therapeutics Stock Chart Apellis Pharmaceuticals Stock Chart Avidity Biosciences Stock Chart Akero Therapeutics Stock Chart PTC Therapeutics Stock Chart Crinetics Pharmaceuticals Stock Chart Rhythm Pharmaceuticals Stock Chart Arcellx Stock Chart Denali Therapeutics Stock Chart Immunovant Stock Chart Receive AVBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVBP) was last updated on 1/30/2025 by MarketBeat.com Staff From Our Partners#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredHot Stock Alert! Biotech innovator on the NYSE announces breakthrough antiviral therapyA revolutionary antiviral drug is here! This breakthrough could mean viruses are unlikely to escape treatment....Smallcaps Daily | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ArriVent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVBP Stock Alerts